Species distribution and antifungal susceptibility patterns of Aspergillus isolates from clinical specimens and soil samples in Mexico
                 
        Academic Article in Scopus 
                     
         
            
    
    
     
        
    
          
      
    
      
            Overview 
              
            Identity 
              
            Additional document info 
              
    View All 
      
 
        
        
            
                 
         
            Overview 
        
            
                    abstract    
                
    
    	© 2021 Oxford University Press. All rights reserved.This study aimed to assess the species distribution and antifungal susceptibility patterns of 200 strains of Aspergillus isolated from clinical specimens (n = 146) and soil samples (n = 54) in Mexico. ITS, ß-tubulin, and calmodulin DNA sequencing was performed for species identification. Broth microdilution susceptibility testing for amphotericin B, voriconazole, posaconazole, itraconazole, isavuconazole, anidulafungin, caspofungin, and micafungin was done according to CLSI for all strains. A. fumigatus was most frequently recovered from clinical specimens, while A. niger was commonly encountered in soil, both followed by A. flavus in the second place. A total of 60 (30%) cryptic species were identified, with A. tubingensis and A. tamarii being the most commonly found. The decreased susceptibility to amphotericin B and azoles was 32% for both, and were mainly led by A. fumigatus, whereas this percentage decreased to 9% for caspofungin, particularly in A. terreus. More than 75% of cryptic species were susceptible in vitro to all antifungals. Multi-azole decreased susceptibility was detected only in seven isolates. Given that antifungal resistance in Aspergillus spp. is an increasing worldwide threat that causes major challenges in the clinical management of aspergillosis, these data highlight the need for continuous epidemiological surveillance of these pathogens for the implementation of locally adequate treatment strategies. 
     
                 
              
            
                    
                
              
            
                    status    
                
              
            
                    publication date    
                
              
            
                    published in    
                
              
         
          
        
        
            
                 
         
            Identity 
        
            
                    Digital Object Identifier (DOI)    
                
              
            
                    PubMed ID    
                
              
         
          
        
        
            
                 
         
            Additional document info 
        
            
                    has global citation frequency    
                
              
            
                    start page    
                
              
            
                    end page    
                
              
            
                    volume